SwePub
Sök i LIBRIS databas

  Extended search

WFRF:(Mattsson Johanna)
 

Search: WFRF:(Mattsson Johanna) > Endoscopic papillec...

Endoscopic papillectomy and KRAS expression in the treatment of adenoma in the major duodenal papilla

Haraldsson, Erik (author)
Karolinska Institutet
Swahn, Fredrik (author)
Karolinska Univ Hosp, Ctr Digest Dis, Stockholm, Sweden.;Karolinska Inst, CLINTEC, Div Surg, Stockholm, Sweden.
Verbeke, Caroline (author)
Karolinska Institutet
show more...
Mattsson, Johanna S. M. (author)
Uppsala universitet,Institutionen för immunologi, genetik och patologi
Enochsson, Lars (author)
Karolinska Institutet
Ung, Kjell-Arne (author)
Skaraborg Hosp, Skovde, Sweden.
Lundell, Lars (author)
Karolinska Institutet
Heuchel, Rainer (author)
Karolinska Institutet
Lohr, J. -Matthias (author)
Karolinska Institutet
Arnelo, Urban (author)
Karolinska Institutet
show less...
Karolinska Institutet Karolinska Univ Hosp, Ctr Digest Dis, Stockholm, Sweden;Karolinska Inst, CLINTEC, Div Surg, Stockholm, Sweden. (creator_code:org_t)
2015-05-15
2015
English.
In: Scandinavian Journal of Gastroenterology. - : Informa UK Limited. - 0036-5521 .- 1502-7708. ; 50:11, s. 1419-1427
  • Journal article (peer-reviewed)
Abstract Subject headings
Close  
  • Objective. The use of endoscopic papillectomy for resecting adenomas in the major duodenal papilla is increasing. This study focuses on the following three issues: Can endoscopic papillectomy be performed as a safe diagnostic and/or therapeutic procedure in biopsy-verified or suspected ampullary adenoma? Does expression of mutated KRAS in resected adenomatous tissue predict long-term outcome? What other factors may affect long-term outcome and should, therefore, be considered in decision making prior to endoscopic papillectomy? Material and methods. Thirty-six prospectively collected patients who underwent endoscopic papillectomy at Karolinska University Hospital between 2005 and 2014 were analyzed. Results. The rate of exact agreement between the histomorphological grading of the endoscopic biopsies and the papillectomy specimens was low (48%). Obstructive jaundice at presentation increased the risk of undetected adenocarcinoma (RR = 3.98; 95% CI = 1.46-10.85, p = 0.007). Lesions with malignancies were significantly larger (mean 30.6 mm) than those where only adenomas were found (mean 14.4 mm, p = 0.001). Mutated KRAS was detected in 9 of the 36 post-papillectomy specimens, including 4 of the 5 cases of ampullary adenocarcinoma. Eighteen cases were endoscopically cured after a mean follow-up period of 47 months (range 16-92 months). Conclusions. Endoscopic papillectomy is a valuable staging tool because of the limitations of endoscopic biopsy. Endoscopic papillectomy concomitantly offers a curative treatment for most patients with adenoma in the major duodenal papilla. Jaundice at presentation and large adenomas may indicate the presence of more advanced disease. Determination of mutated KRAS seems to be of limited value in predicting long-term outcome.

Subject headings

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Gastroenterologi (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Gastroenterology and Hepatology (hsv//eng)
MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Kirurgi (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Surgery (hsv//eng)

Keyword

ampulla of vater
ampullectomy
endoscopic resection
endoscopic retrograde cholangiopancreatography
KRAS mutation

Publication and Content Type

ref (subject category)
art (subject category)

Find in a library

To the university's database

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view